121 related articles for article (PubMed ID: 21301321)
21. Cyclooxygenase-2 (COX-2) is directly involved but not decisive in proliferation of human hepatocellular carcinoma cells.
Park JW; Park JE; Lee JA; Lee CW; Kim CM
J Cancer Res Clin Oncol; 2006 Mar; 132(3):184-92. PubMed ID: 16331492
[TBL] [Abstract][Full Text] [Related]
22. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
[TBL] [Abstract][Full Text] [Related]
23. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
[TBL] [Abstract][Full Text] [Related]
24. Radiation sensitivity of human carcinoma cells transfected with small interfering RNA targeted against cyclooxygenase-2.
Palayoor ST; Arayankalayil MJ; Shoaibi A; Coleman CN
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6980-6. PubMed ID: 16203791
[TBL] [Abstract][Full Text] [Related]
25. The cyclin-dependent kinase 2 inhibitor down-regulates interleukin-1beta-mediated induction of cyclooxygenase-2 expression in human lung carcinoma cells.
Mukhopadhyay P; Ali MA; Nandi A; Carreon P; Choy H; Saha D
Cancer Res; 2006 Feb; 66(3):1758-66. PubMed ID: 16452236
[TBL] [Abstract][Full Text] [Related]
26. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.
Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT
J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis.
Zhang DY; Wu J; Ye F; Xue L; Jiang S; Yi J; Zhang W; Wei H; Sung M; Wang W; Li X
Cancer Res; 2003 Jul; 63(14):4037-43. PubMed ID: 12874003
[TBL] [Abstract][Full Text] [Related]
28. Cyclooxygenase-2 inhibition suppresses alphavbeta6 integrin-dependent oral squamous carcinoma invasion.
Nystrom ML; McCulloch D; Weinreb PH; Violette SM; Speight PM; Marshall JF; Hart IR; Thomas GJ
Cancer Res; 2006 Nov; 66(22):10833-42. PubMed ID: 17108119
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
St John MA
Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
[TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor-induced COX-2 regulates metastasis of head and neck squamous cell carcinoma through upregulation of angiopoietin-like 4.
Chiang KH; Shieh JM; Shen CJ; Chang TW; Wu PT; Hsu JY; Tsai JP; Chang WC; Chen BK
Cancer Sci; 2020 Jun; 111(6):2004-2015. PubMed ID: 32227417
[TBL] [Abstract][Full Text] [Related]
31. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma.
Leung WK; To KF; Go MY; Chan KK; Chan FK; Ng EK; Chung SC; Sung JJ
Int J Oncol; 2003 Nov; 23(5):1317-22. PubMed ID: 14532971
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
33. PGE2 production in oral cancer cell lines is COX-2-dependent.
Husvik C; Khuu C; Bryne M; Halstensen TS
J Dent Res; 2009 Feb; 88(2):164-9. PubMed ID: 19278989
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of selective cyclooxygenase-2 inhibitors in inhibiting proliferation and induction of apoptosis in oral squamous cell carcinoma.
Ko SH; Choi GJ; Lee JH; Han YA; Lim SJ; Kim SH
Oncol Rep; 2008 Feb; 19(2):425-33. PubMed ID: 18202791
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity.
Yu L; Wu WK; Li ZJ; Liu QC; Li HT; Wu YC; Cho CH
Mol Pharmacol; 2009 Jun; 75(6):1364-73. PubMed ID: 19264847
[TBL] [Abstract][Full Text] [Related]
36. The effect of nitric oxide on cyclooxygenase-2 (COX-2) overexpression in head and neck cancer cell lines.
Park SW; Lee SG; Song SH; Heo DS; Park BJ; Lee DW; Kim KH; Sung MW
Int J Cancer; 2003 Dec; 107(5):729-38. PubMed ID: 14566822
[TBL] [Abstract][Full Text] [Related]
37. Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model.
Zhang X; Chen ZG; Choe MS; Lin Y; Sun SY; Wieand HS; Shin HJ; Chen A; Khuri FR; Shin DM
Clin Cancer Res; 2005 Sep; 11(17):6261-9. PubMed ID: 16144930
[TBL] [Abstract][Full Text] [Related]
38. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells.
Pelzmann M; Thurnher D; Gedlicka C; Martinek H; Knerer B
J Oral Pathol Med; 2004 Nov; 33(10):607-13. PubMed ID: 15482327
[TBL] [Abstract][Full Text] [Related]
39. Cryptotanshinone inhibits cyclooxygenase-2 enzyme activity but not its expression.
Jin DZ; Yin LL; Ji XQ; Zhu XZ
Eur J Pharmacol; 2006 Nov; 549(1-3):166-72. PubMed ID: 16989810
[TBL] [Abstract][Full Text] [Related]
40. Cyclooxygenase-2 expression is induced by celecoxib treatment in lung cancer cells and is transferred to neighbor cells via exosomes.
Kim J; Hong SW; Kim S; Kim D; Hur DY; Jin DH; Kim B; Kim YS
Int J Oncol; 2018 Feb; 52(2):613-620. PubMed ID: 29345286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
